Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Much ado about nothing
View:
Post by Marcel7 on Feb 23, 2016 8:04am

Much ado about nothing

Looks like the Valeant restate of financials is not a big deal. 2014 EPS reduced by 9 cents 2015 EPS increased by 10 cents. If anything clearing everything up with Philidor and moving forward is a good thing for theme. Hopefully we see CXR recover a bit as VRX recovers today. If VRX reports good earnings on Feb 29 that could also help us a bit. GLTA Marcel
Comment by visionaryfool on Feb 23, 2016 8:53am
Man, VRX... what a roller coaster. Post-markets yesterday down 10%, pre-markets today up 2%. Very happy to see the news was overblown! Hopefully we'll see some base and staiblity for CXR. Tomorrow's JP Morgan conference should help a little.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities